Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
International Journal of Cancer
|
July 29, 1998
Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy
U Naumann, M Weller
Biochemical and Biophysical Research Communications
|
June 28, 1991
Complete cDNA and gene sequence of the developmentally regulated arylphorin of Calliphora vicina and its homology to insect hemolymph proteins and arthropod hemocyanins
U Naumann, K Scheller
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
June 24, 2009
Automation in high-content flow cytometry screening
U Naumann, M P Wand
Experimental Cell Research
|
December 10, 1999
Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status
C Bartussek, U Naumann, M Weller
Geburtshilfe Und Frauenheilkunde
|
May 1, 1986
[The cardiotocography instrument test]
J Morgenstern, U Naumann, T Somville
Der Nervenarzt
|
June 6, 2008
[An unusual case of anterior communicating artery syndrome]
U Naumann, G Juckel, M Brüne
Oncogene
|
October 30, 1998
Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
U Naumann, S Durka, M Weller
Cell and Tissue Research
|
June 26, 1999
Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth
M Ständer, U Naumann, W Wick, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
June 3, 1999
p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis
U Pohl, B Wagenknecht, U Naumann, et al.
Zeitschrift Fur Gastroenterologie
|
March 20, 2001
Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C
T Berg, U Naumann, B Wiedenmann, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
International Journal of Cancer
|
July 29, 1998
Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy
U Naumann, M Weller
Biochemical and Biophysical Research Communications
|
June 28, 1991
Complete cDNA and gene sequence of the developmentally regulated arylphorin of Calliphora vicina and its homology to insect hemolymph proteins and arthropod hemocyanins
U Naumann, K Scheller
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
June 24, 2009
Automation in high-content flow cytometry screening
U Naumann, M P Wand
Experimental Cell Research
|
December 10, 1999
Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status
C Bartussek, U Naumann, M Weller
Geburtshilfe Und Frauenheilkunde
|
May 1, 1986
[The cardiotocography instrument test]
J Morgenstern, U Naumann, T Somville
Der Nervenarzt
|
June 6, 2008
[An unusual case of anterior communicating artery syndrome]
U Naumann, G Juckel, M Brüne
Oncogene
|
October 30, 1998
Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
U Naumann, S Durka, M Weller
Cell and Tissue Research
|
June 26, 1999
Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth
M Ständer, U Naumann, W Wick, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
June 3, 1999
p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis
U Pohl, B Wagenknecht, U Naumann, et al.
Zeitschrift Fur Gastroenterologie
|
March 20, 2001
Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C
T Berg, U Naumann, B Wiedenmann, et al.
Page
of 10